Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Ursodeoxycholic Acid (125mg/5ml)
Therapeutic Category
Hepatology, Gastroenterology
Dosage Form
Suspension
Packaging Type
with Carton
Packaging
100 ml
Price
₹450/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Uriviga Suspension is a pharmaceutical formulation that contains Ursodeoxycholic Acid as its active ingredient, providing 125 mg of the compound per 5 ml. This medication is primarily indicated for the treatment of certain liver disorders, including cholestatic liver diseases and gallstones, as it helps improve bile flow and reduce the concentration of toxic bile acids in the liver. By promoting better liver function, Urivigo can aid in alleviating symptoms associated with bile acid accumulation.
Ursodeoxycholic Acid works by facilitating the solubilization of cholesterol and reducing its absorption, which can lead to the dissolution of cholesterol gallstones. Additionally, it has protective effects on liver cells and can help maintain liver function in various hepatic conditions. This makes Urivigo Suspension a valuable option for patients needing liver support during treatment.
Possible side effects may include diarrhea, abdominal pain, and nausea. Patients should consult their healthcare provider if severe reactions occur.
Used in the treatment of cholestatic liver diseases and for dissolving cholesterol gallstones.
Always follow your healthcare provider’s instructions regarding dosage and duration of therapy, and inform them of any other medications you are taking. Overall, Urivigo Suspension represents a crucial treatment option for patients suffering from liver-related conditions. With its dual action of aiding bile flow and protecting liver cells, it is essential for those seeking to manage their liver health effectively. Before starting this medication, patients should engage in a thorough discussion with their healthcare professional to ensure it is appropriate for their specific condition and to understand the full scope of potential benefits and risks.
Store at room temperature, away from moisture and heat, and keep out of reach of children.
Composition : Ursodeoxycholic Acid (450mg) SR
Composition : Ursodeoxycholic Acid (600mg) SR
Composition : Ursodeoxycholic Acid (300mg)
Composition : Ursodeoxycholic Acid (150mg)
Composition : Obeticholic acid (10mg) Tablet
Composition : Obeticholic acid (5mg) Tablet
Composition : Cinitapride (3mg) + Pantoprazole (40mg)
Composition : Omeprazole (20mg) Capsule
Composition : Pantoprazole (20mg)
Composition : Pantoprazole (40mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Ursodeoxycholic Acid 125mg/5ml Suspension has strong demand in the hepatology, gastroenterology, pediatric care, and liver health segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on liver care and digestive health portfolios.
Medical distributors and agencies can benefit from growing demand for liver and biliary disorder management under medical supervision. Ursodeoxycholic Acid (UDCA) 125mg/5ml is a bile acid commonly used in the management of various liver and biliary tract disorders Commonly prescribed for cholestatic liver diseases, gallstone management in selected patients, biliary disorders, and certain pediatric liver conditions as advised by healthcare professionals Helps improve bile flow and supports normal liver function Suspension formulation is particularly suitable for pediatric patients and individuals who have difficulty swallowing tablets or capsules Widely prescribed by hepatologists, gastroenterologists, pediatricians, and physicians This strengthens a comprehensive liver care and gastroenterology portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Ursodeoxycholic Acid 125mg/5ml Suspension with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from growing demand in the liver care segment, specialist-driven prescriptions, repeat orders, reliable supply chain support, and attractive margins in the gastroenterology and hepatology market.
Interested distributors, stockists, and wholesalers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality product ranges, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.